Edition:
United States

GeneNews Ltd (GEN.TO)

GEN.TO on Toronto Stock Exchange

0.09CAD
21 Sep 2017
Change (% chg)

$-0.00 (-5.26%)
Prev Close
$0.09
Open
$0.10
Day's High
$0.10
Day's Low
$0.09
Volume
106,265
Avg. Vol
420,534
52-wk High
$0.57
52-wk Low
$0.09

Chart for

About

GeneNews Limited is focused on developing and commercializing molecular diagnostic tests for early detection of diseases and for personalized health management, with a primary focus on cancer-related indications. The Company offers Sentinel Principle, which is a platform technology to detect virtually any disease or medical... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $9.19
Shares Outstanding(Mil.): 96.48
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 78.94 16.33
EPS (TTM): -- -- --
ROI: -- 2.84 14.66
ROE: -- 4.61 13.99

BRIEF-GeneNews Q2 loss per share $0.01

* GeneNews announces Q2-2017 financial results & provides progress update

Aug 15 2017

BRIEF-GeneNews announces extension of warrant exercise incentive program

* GeneNews announces extension of warrant exercise incentive program

Jul 14 2017

BRIEF-GENENEWS SIGNS BINDING COMMITMENT LETTER WITH MILOST GLOBAL FOR $10 MLN FINANCING

* GENENEWS SIGNS BINDING COMMITMENT LETTER WITH MILOST GLOBAL FOR US$10 MILLION FINANCING

Jun 29 2017

BRIEF-GeneNews announces repricing of GEM Warrants

* Applied to TSX to amend exercise price of outstanding common share purchase warrants of co as issued to GEM Global Yield Fund LLC SCS

Jun 12 2017

BRIEF-Genenews Q1 loss per share $0.02

* Genenews announces q1-2017 financial results & provides progress update

May 11 2017

BRIEF-Genenews reports Q4 EPS $0.02

* Genenews announces fourth quarter and full year 2016 financial results

Apr 03 2017

Earnings vs. Estimates

No consensus analysis data available.